The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
Authors:
- Leslie A. GeerLGLeslie A. Geer
- Kanyin E. ZhangKZKanyin E. Zhang
- Tina M. MarksTMTina M. Marks
- Dennis C. DeanDDDennis C. Dean
- Allen N. JonesAJAllen N. Jones
- David MelilloDMDavid Melillo
- George DossGDGeorge Doss
- Kamlesh P. VyasKVKamlesh P. Vyas
- 1 October 2000
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (10) , 1244-1254
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitorBioorganic & Medicinal Chemistry Letters, 1999
- Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansClinical Pharmacology & Therapeutics, 1999
- Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain modelClinical Pharmacology & Therapeutics, 1999
- Review article: COX‐II inhibitors—a new generation of safer NSAIDs?Alimentary Pharmacology & Therapeutics, 1997
- Prostaglandin Endoperoxide H Synthases-1 and -21996
- Prostaglandin endoperoxide synthase: structure and catalysisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.Journal of Biological Chemistry, 1990
- Laser desorption/fourier transform ion cyclotron resonance mass spectrometry: Digoxin, digitoxin, and their reduced and sugar-hydrolyzed metabolitesJournal of Mass Spectrometry, 1988
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971